Tumor infiltration of the immune cells, including CD8-positive T cells and NK cells, was increased with CTLA-4 blockade, while a reduction in the proportion of tumor-infiltrating NK cells that were exhausted and differentiated was observed with IL-2 (329). The gene discussed is CD8A; the disease is neoplasm.